PATH Program for Burnout
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called PATH (Peer Advanced Training in Harm reduction), designed to help peer recovery support specialists (PRSS) reduce burnout and enhance their skills in harm reduction services. Harm reduction includes strategies to lessen the negative impacts of drug use, such as syringe services or outreach. The trial will evaluate whether PATH, which features online education and case discussions, can improve service quality and reduce worker stress. Individuals working at organizations that offer harm reduction services and are involved in direct service delivery might be well-suited for this trial. As a Phase 2 trial, this research focuses on measuring the effectiveness of the PATH program in an initial, smaller group, offering participants a chance to contribute to improving harm reduction services.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the PATH program is safe for participants?
Research on the PATH (Peer Advanced Training in Harm reduction) program has primarily examined its effectiveness in reducing burnout among peer recovery support specialists. However, specific information about its safety or potential side effects remains limited. Since the program involves education and consultation rather than medication or medical procedures, the risks are likely very low.
This trial is a Phase 2 study, indicating that earlier tests have demonstrated the program's safety and effectiveness, warranting further research. Phase 2 trials typically focus on refining the program and assessing its efficacy, suggesting that earlier studies have addressed any major safety concerns.
Overall, participating in PATH is likely low-risk, as it involves online education and case-based consultation rather than physical treatment.12345Why are researchers excited about this trial?
Researchers are excited about the PATH program because it focuses on a peer-based approach to tackle burnout, which is different from the usual reliance on individual interventions like therapy or medication. Unlike traditional methods that primarily target stress relief at the individual level, PATH emphasizes harm reduction through community support and peer training. This method holds promise for creating sustainable, supportive environments that can better prevent and manage burnout over time.
What evidence suggests that the PATH program is effective for reducing burnout?
Research has shown that the PATH program, which stands for Peer Advanced Training in Harm Reduction, might help reduce burnout among peer recovery support specialists. It uses online education and real-life case discussions to improve the quality of harm reduction services and support the workforce. Studies have demonstrated that similar training programs effectively reduce burnout by enhancing job skills and support systems. PATH aims to strengthen these areas, potentially leading to better outcomes for both workers and those they assist.678910
Who Is on the Research Team?
Dennis P Watson, PhD
Principal Investigator
Chestnut Health Systems
Are You a Good Fit for This Trial?
This trial is for peer recovery support specialists (PRSS) who provide harm reduction services. It aims to help them improve their service delivery and reduce burnout. Participants should be currently active in the field of harm reduction.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
eLearning
Participants complete 3 hours of eLearning modules as part of the PATH intervention
ECHO Meetings
Participants attend 8 weekly ECHO meetings, each lasting 1.5 hours, including presentations and case-based discussions
Follow-up
Participants complete surveys and qualitative assessments to evaluate training satisfaction and impact
What Are the Treatments Tested in This Trial?
Interventions
- PATH (Peer Advanced Training in Harm reduction)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Chestnut Health Systems
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator